We are live on
!
Find out more
SNSE
Sensei Biotherapeutics
SNSE
SNSE
Delisted
SNSE was delisted on the 15th of June, 2026.
30 hedge funds and large institutions have $4.47M invested in Sensei Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$246K | |
| 2 | +$39.3K | |
| 3 | +$22.8K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$20.6K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.18K |
Top Sellers
| 1 | -$189K | |
| 2 | -$134K | |
| 3 | -$107K | |
| 4 |
Renaissance Technologies
New York
|
-$81K |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$78.6K |